Vagifem is a popular form of localised hormone replacement therapy (HRT) that has been successfully used by millions of women in menopause since it was first licensed in 1999. As a targeted treatment, it replaces oestrogen only in the vaginal area, providing valuable relief from the symptoms of dryness, discomfort and irritation but with fewer risks than those associated with oral HRT.